Biotechnology, one of molecular biology’s branches, monitored and intentional manipulation of biological organisms, processes or systems to effectively make or process drugs, or any other products and substances useful to enhancing people’s living quality. The earliest examples of humans applying their knowledge of biotechnology involved the efforts to enhance plants and animals’ species by cross-pollination (allogamy) or cross-breeding.
Biotechnology has recently turned to a more sophisticated business, considerably enlarged in scale and application range. Having goodly restored from the recession, the world Biotechnology Market is anticipated to be eventually estimated at far over EUR 245 billion by end-2015. However, with the numerous benefits this advanced technology comes laden with, there are worries about its potential misuse. Concerns over this issue has trailed into some attempting to facilitate the enforcement of specific laws constraining or even banning relevant programs and research (e.g. human cloning).
The research reports from this Catalogue offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.
Publications found:
1,366
Sort by:
Middle East & Africa Biopharmaceuticals Market Forecast to 2028 -Regional Analysis - by Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
US$ 3,000.00
The Middle East & Africa biopharmaceuticals market was valued at US$ 13.36 billion in 2022 and is projected to reach US$ 28.81 billion by 2028. It is estimated to register a CAGR of 13.7% from 2022 to...
July 2023
230 pages
Global Nanobiotechnology Market Size study & Forecast, by Product (Nanobiotechnology instruments, Nanobiotechnology services, and Nanobiotechnology products), by Application (Drug Delivery, Genomics, Proteomics, Diagnostics, and Others), by Technology (Nanoparticles, Nanotubes, Nanoshells, and Others), by End-use (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Diagnostic Laboratories, and Others) and Regional Analysis, 2023-2030
US$ 4,950.00
Global Nanobiotechnology Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Nanobiotech...
July 2023
200 pages
Global Tissue Engineering and Regeneration Market Size study & Forecast, by Product (Biomaterials, Cell Therapy, Tissue Engineering), by Application (Orthopedics, Dermatology, Cardiology, Neurology, Others) and Regional Analysis, 2023-2030
US$ 4,950.00
Global Tissue Engineering and Regeneration Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023...
July 2023
200 pages
CRISPR Market by Product (Enzymes, Kits, Libraries), Services (gRNA design, Cell Line Engineering, Screening), Application (Drug Discovery & Development, Agriculture), End User (Pharma, Biotech, CROs, Research Institutes) - Global Forecast to 2028
US$ 4,950.00
... segment is the faster-growing segment in the CRISPR technology market, by product and service. Based on services, the CRISPR services market is segmented into gRNA design and vector ...
June 2023
200 pages
Asia Pacific Biopharmaceuticals Market Forecast to 2028 -Regional Analysis - by Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
US$ 3,000.00
The Asia Pacific biopharmaceuticals market was valued at US$ 39.96 billion in 2022 and is expected to reach US$ 94.13 billion by 2028. It is estimated to register a CAGR of 15.3% from 2022 to 2028. A...
June 2023
250 pages
Asia Pacific Enzymatic DNA Synthesis Market Forecast to 2028 -Regional Analysis - by Product Type (Custom DNA Synthesis and DNA Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, and Others), Technology (SOLA, CRISPR, PCR, and Others), and End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, and Others)
US$ 3,000.00
The Asia Pacific enzymatic DNA synthesis market is expected to grow from US$ 29.18 million in 2022 to US$ 301.49 million by 2028. It is estimated to record a CAGR of 47.6% from 2022 to 2028. Growing...
June 2023
146 pages
Cell based Assays Market by Product & Service (Reagents, Assays Kits, Cell Lines, Microplates, Probes & Labels, Instruments & Software), Application (Drug Discovery (Toxicity, Pharmacokinetics), Research), End User (CROS, Pharma) & Region - Global Forecast to 2028
US$ 4,950.00
... players in the cell-based assays market Market Development: Comprehensive information about emerging markets. This report analyzes the market for various cell-based assays across geographies Market Diversification: Exhaustive information ...
June 2023
340 pages
Biosimilars Market by Drug Class (Drug Class (Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab), Insulin, Erythropoietin, Anticoagulants. rhGH), Indication, Region – Global Forecast to 2028
US$ 4,950.00
... the forecast period.” The biosimilars market by product, is categorized into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. The recombinant glycosylated proteins segment is expected ...
June 2023
298 pages
Biotechnology Market Research (China)
US$ 4,000.00
China's demand for Biotechnology has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
June 2023
256 pages
Biologics Markets in China
US$ 4,000.00
China's demand for Biologics has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
June 2023
243 pages
Biologics Industry Forecasts - China Focus
US$ 1,800.00
This study focuses on China’s Biologics industry forecasts. In the two past decades, the ... long-term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...
June 2023
99 pages
Biotechnology Industry Forecasts - China Focus
US$ 1,800.00
This study focuses on China’s Biotechnology industry forecasts. In the two past decades, the ... -term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...
June 2023
102 pages
Biologics Companies in China
US$ 1,800.00
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
June 2023
82 pages
Biotechnology Companies in China
US$ 1,800.00
This study focuses on China’s Biotechnology industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
June 2023
116 pages
Next Generation Sequencing (NGS) Market - A Global and Regional Analysis: Focus on Offering, Company, Throughput, Technology Type, Sequencing, Application, End User, and Country Analysis - Analysis and Forecast, 2023-2033
US$ 5,500.00
Global NGS Market: Industry Overview The global NGS market was valued at $6.76 billion in 2022 and is expected to reach $28.47 billion by 2033, growing at a CAGR of 13.97% during the forecast period 2...
June 2023
385 pages
Organoids Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells), and Geography
US$ 4,550.00
The organoids market is expected to grow from US$ 2.50 billion in 2022 to US$ 8.12 billion by 2028; it is estimated to register a CAGR of 21.8% from 2022 to 2028. The increasing demand for tumor model...
May 2023
196 pages
Nanoparticle Formulation Market: Technologies and Services - Distribution by Type of Nanoparticle Formulated (Organic Nanoparticles (Polymeric Nanoparticles, Lipid Nanoparticles, Viral Nanoparticles, Protein-based Nanoparticles and Other Organic Nanoparticles), Inorganic Nanoparticles and Carbon-based Nanoparticles), Scale of Operation (Preclinical, Clinical and Commercial) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The global nanoparticle formulation market is expected to reach USD 5.1 billion in 2023 anticipated to grow at a CAGR of 9.4% during the forecast period 2023-2035. Over time, nanoparticles have evolve...
May 2023
246 pages
Cell Isolation/ Cell Separation Market by Product (Consumables, Instruments), Cell Type (Human Cells, Animal Cells), Cell Source (Bone Marrow, Adipose Tissues), Technique (Centrifugation-based), Application, End User (Pharma) - Global Forecast to 2028
US$ 4,950.00
... Research Coverage: The report analyzes the cell isolation market by product, cell type, cell source, technique, application, end user, ... cell isolation market Market Development: Detailed information about emerging markets. The report analyzes the market for various cell isolation across geographies Market ...
May 2023
309 pages
Asia Pacific Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
US$ 3,000.00
The Asia Pacific blood plasma derivatives market was valued at US$ 6,324.33 million in 2022 and is projected to reach US$ 11,118.43 million by 2028; it is expected to grow at a CAGR of 9.9% from 2022...
May 2023
158 pages
Asia Pacific Stem Cell Therapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes)
US$ 3,000.00
The Asia Pacific stem cell therapy market was valued at US$ 403.94 million in 2022 and is projected to reach US$ 1,180.20 million by 2028; it is expected to grow at a CAGR of 19.6% from 2022 to 2028....
May 2023
141 pages
Europe Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
US$ 3,000.00
The Europe blood plasma derivatives market was valued at US$ 8,474.00 million in 2022 and is projected to reach US$ 14,262.27 million by 2028; it is expected to grow at a CAGR of 9.1% from 2022 to 202...
May 2023
158 pages
Europe Stem Cell Therapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes)
US$ 3,000.00
The Europe stem cell therapy market was valued at US$ 446.75 million in 2022 and is projected to reach US$ 1,209.01 million by 2028; it is expected to grow at a CAGR of 18.0% from 2022 to 2028. Growi...
May 2023
144 pages
Middle East & Africa Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
US$ 3,000.00
The Middle East & Africa blood plasma derivatives market was valued at US$ 1,402.51 million in 2022 and is projected to reach US$ 2,223.69 million by 2028; it is expected to grow at a CAGR of 8.0% fro...
May 2023
145 pages
North America Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
US$ 3,000.00
The North America blood plasma derivatives market was valued at US$ 11,821.24 million in 2022 and is projected to reach US$ 20,447.70 million by 2028; it is expected to grow at a CAGR of 9.6% from 202...
May 2023
137 pages
North America Stem Cell Therapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes)
US$ 3,000.00
The North America stem cell therapy market was valued at US$ 1,299.39 million in 2022 and is projected to reach US$ 3,582.26 million by 2028; it is expected to grow at a CAGR of 18.4% from 2022 to 202...
May 2023
133 pages
South & Central America Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
US$ 3,000.00
The South & Central America blood plasma derivatives market was valued at US$ 1,864.04 million in 2022 and is projected to reach US$ 3,067.15 million by 2028; it is expected to grow at a CAGR of 8.7%...
May 2023
137 pages
Organ Preservation Solution Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type [University of Wisconsin Solution (UW), Custodiol HTK, Perfadex, Hypothermosol, and Others], Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), Organ Type (Kidneys, Liver, Lungs, Heart, and Others), and End User (Organ Transplant Centers, Hospitals, and Specialty Clinics)
US$ 4,550.00
According to our new research study on 'Organ Preservation Solution Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Application, Organ Type, and End User,' the market was valu...
May 2023
211 pages
Genomics Market by Product & Service (Consumables, Instrument, System & Software), Technology (Sequencing, PCR, Microarray), Study Type (Epigenomics, Biomarker Discovery), Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2028
US$ 4,950.00
... at the highest CAGR during the forecast period” Based on product & service, the genomics market is segmented into consumables, systems & software, and services ... major players operating in this market. Research coverage: This report studies the genomics market based on product and service, application, end user ...
April 2023
395 pages
Asia Pacific Enzymatic DNA Synthesis Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Custom DNA Synthesis and DNA Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, and Others), and End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, and Others)
US$ 3,000.00
The Asia Pacific enzymatic DNA synthesis market is expected to grow from US$ 29.18 million in 2022 to US$ 301.49 million by 2028. It is estimated to register a CAGR of 47.6% from 2022 to 2028. Rising...
April 2023
129 pages
Europe Enzymatic DNA Synthesis Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Custom DNA Synthesis and DNA Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, and Others), and End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, and Others)
US$ 3,000.00
The Europe enzymatic DNA synthesis market is expected to grow from US$ 78.55 million in 2022 to US$ 727.79 million by 2028. It is estimated to register a CAGR of 44.9% from 2022 to 2028. Growing Deman...
April 2023
131 pages
Middle East & Africa Enzymatic DNA Synthesis Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Custom DNA Synthesis and DNA Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, and Others), and End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, and Others)
US$ 3,000.00
The Middle East & Africa enzymatic DNA synthesis market is expected to grow from US$ 9.76 million in 2022 to US$ 92.26 million by 2028. It is estimated to register a CAGR of 45.4% from 2022 to 2028. G...
April 2023
116 pages
North America Biosimilars Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Disease Indication (Cancer, Diabetes, Autoimmune Diseases, and Other Diseases), Drug Class (Granulocyte Colony-Stimulating Factors, Human Growth Hormone, Insulin, TNF Blockers & Monoclonal Antibodies, Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others)
US$ 3,000.00
The North America biosimilars market is expected to grow from US$ 7,115.74 million in 2022 to US$ 47,746.80 million by 2028. It is estimated to grow at a CAGR of 37.3% from 2022 to 2028. Increasing Pr...
April 2023
166 pages
North America Enzymatic DNA Synthesis Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Custom DNA Synthesis and DNA Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, and Others), and End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, and Others)
US$ 3,000.00
The North America enzymatic DNA synthesis market is expected to grow from US$ 110.43 million in 2022 to US$ 1,011.32 million by 2028. It is estimated to register a CAGR of 44.6% from 2022 to 2028. Ris...
April 2023
122 pages
South America Biosimilars Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Disease Indication (Cancer, Diabetes, Autoimmune Diseases, and Other Diseases), Drug Class (Granulocyte Colony-Stimulating Factors, Human Growth Hormone, Insulin, TNF Blockers & Monoclonal Antibodies, Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others)
US$ 3,000.00
The South America biosimilars market is expected to grow from US$ 1,394.55 million in 2022 to US$ 8,449.92 million by 2028. It is estimated to grow at a CAGR of 35.0% from 2022 to 2028. Collaborations...
April 2023
147 pages
South & Central America Enzymatic DNA Synthesis Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Custom DNA Synthesis and DNA Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, and Others), and End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, and Others)
US$ 3,000.00
The South & Central America enzymatic DNA synthesis market is expected to grow from US$ 13.04 million in 2022 to US$ 112.02 million by 2028. It is estimated to register a CAGR of 43.1% from 2022 to 20...
April 2023
112 pages
Europe Biosimilars Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Disease Indication (Cancer, Diabetes, Autoimmune Diseases, and Other Diseases), Drug Class (Granulocyte Colony-Stimulating Factors, Human Growth Hormone, Insulin, TNF Blockers & Monoclonal Antibodies, Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others)
US$ 3,000.00
The Europe biosimilars market is expected to grow from US$ 10,188.49 million in 2022 to US$ 56,373.61 million by 2028. It is estimated to grow at a CAGR of 33.0% from 2022 to 2028. Cost Effectiveness...
April 2023
170 pages
Middle East & Africa Biosimilars Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Disease Indication (Cancer, Diabetes, Autoimmune Diseases, and Other Diseases), Drug Class (Granulocyte Colony-Stimulating Factors, Human Growth Hormone, Insulin, TNF Blockers & Monoclonal Antibodies, Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others)
US$ 3,000.00
The Middle East & Africa biosimilars market is expected to grow from US$ 1,190.50 million in 2022 to US$ 6,408.87 million by 2028. It is estimated to grow at a CAGR of 32.4% from 2022 to 2028. Collabo...
April 2023
158 pages
Asia Pacific Biosimilars Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Disease Indication (Cancer, Diabetes, Autoimmune Diseases, and Other Diseases), Drug Class (Granulocyte Colony-Stimulating Factors, Human Growth Hormone, Insulin, TNF Blockers & Monoclonal Antibodies, Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others)
US$ 3,000.00
The Asia Pacific biosimilars market is expected to grow from US$ 3,141.28 million in 2022 to US$ 22,533.11 million by 2028. It is estimated to grow at a CAGR of 38.9% from 2022 to 2028. Patent Expiry...
April 2023
176 pages
Asia-Pacific and Middle East NGS Market: Focus on Offering, Platform, Throughput, Technology Type, Application, End User, and Country Analysis - Analysis and Forecast, 2022-2027
US$ 5,500.00
Asia-Pacific and Middle East NGS Market Industry Overview The Asia-Pacific and Middle East NGS market was valued at $1,055.6 million in 2022 and is anticipated to reach $2,370.7 million by 2027, witne...
April 2023
217 pages
Gene Switch / Molecular Switch Market - Distribution by Application Area (Management of Treatment Related Toxicity, Regulation of Gene Expression and Other Applications), Type of Target Therapy (CAR T Cell Therapy, Gene Therapy and Other Therapies), Type of Payment Model Employed (Upfront Payments and Milestone Payments), and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The global gene switch / molecular switch market is expected to reach USD 670 million in 2023 anticipated to grow at a CAGR of 11.5% during the forecast period 2023-2035. In recent years, the field of...
April 2023
210 pages
Digital Manufacturing Market for Biologics: Distribution by Type of Technology (Process Analytical Technology, Data Analysis Software, Manufacturing Execution System and Digital Twin), Deployment Options (Cloud-based and On-premises), Type(s) of Biologic(s) Manufactured (Antibodies, Cell Therapies and Gene Therapies, Proteins, Vaccines, and Others), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa): Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The global digital manufacturing market is anticipated to grow at a CAGR of 18% during the forecast period 2023-2035. The pharmaceutical industry has exhibited substantial interest in undergoing digit...
March 2023
254 pages
Aseptic Fill Finish Manufacturing Market by Type of Molecule (Small Molecules and Biologics), Type of Packaging Container Offered (Ampoules, Cartridges, Prefilled Syringe and Vials), Type of Drug Product (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Products), Scale of Operation (Preclinical / Clinical and Commercial), Company Size (Large, Mid-sized and Small), Target Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases Oncological Disorders, and Other Disorders) and Geographical Regions (North America, Europe, Asia Pacific, Middle East and North Africa and Latin America): Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The aseptic fill finish market is expected to reach USD 5.4 billion in 2023 anticipated to grow at a CAGR of 9% during the forecast period 2023-2035. The term 'aseptic fill finish' encapsulates the me...
March 2023
270 pages
Biopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
US$ 4,550.00
The biopharmaceuticals market is expected to grow from US$ 3,29,966.22 million in 2022 to US$ 7,00,873.94 million by 2028; it is expected to grow at a CAGR of 13.4% from 2022 to 2028. Rising applicati...
March 2023
346 pages
